PressAugust 18, 2020 Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
PressAugust 13, 2020 Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
PressAugust 12, 2020 GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering
PressAugust 12, 2020 Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
PressAugust 11, 2020 USF Connect’s Tampa Bay Technology Incubator Propels Homegrown Researchers at Biotech Startup Psilera Bioscience
PressAugust 10, 2020 Cybin Applauds TheraPsil’s Advocacy to Bring Psilocybin Therapy to Palliative Care of Canadian Patients
PressAugust 6, 2020 MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy
PressAugust 5, 2020 Nutritional High Announces Settlement of Payables and Update on Psychedelic Sciences Corp Acquisition.
PressAugust 5, 2020 Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule
PressAugust 4, 2020 Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness
PressAugust 3, 2020 Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis
PressJuly 31, 2020 Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
PressJuly 30, 2020 Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.
PressJuly 30, 2020 Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness
PressJuly 29, 2020 Cybin Corp. to Deliver Psychedelic Medicines Targeting Conditions Failed by Big Pharma
PressJuly 29, 2020 Numinus Announces Short Form Prospectus Offering of Units for Gross Proceeds of up to $4,050,000